Five components of IBS-SS: baseline vs glutamine treatment
| Mean+SD | Pre-post change (mean+SD) | |
| Abdominal distension/bloating | ||
| Baseline | 57.54±13.77 | −5.33±11.85 |
| Treatment endpoint | 52.20±13.60 | P=0.0017 |
| Abdominal pain frequency | ||
| Baseline | 57.93±14.40 | −17.65±18.73 |
| Treatment endpoint | 40.28±12.65 | P<0.0001 |
| Abdominal pain severity | ||
| Baseline | 62.80±16.87 | −34.76±23.26 |
| Treatment endpoint | 28.04±13.09 | P<0.0001 |
| Quality of life | ||
| Baseline | 63.26±16.60 | −33.22±23.10 |
| Treatment endpoint | 30.04±12.95 | P<0.0001 |
| Satisfaction with bowel habits | ||
| Baseline | 59.31±17.94 | −28.56±24.18 |
| Treatment endpoint | 30.76±14.22 | P<0.0001 |
The p value was computed using the paired t-test.
IBS-SS, Irritable Bowel Syndrome Severity Scoring System.